78 related articles for article (PubMed ID: 22176282)
1. Time to discontinuation among the three second-generation antidepressants in a naturalistic outpatient setting of depression.
Lee YM; Lee KU
Psychiatry Clin Neurosci; 2011 Dec; 65(7):630-7. PubMed ID: 22176282
[TBL] [Abstract][Full Text] [Related]
2. Comparisons of the efficacy and tolerability of extended-release venlafaxine, mirtazapine, and paroxetine in treatment-resistant depression: a double-blind, randomized pilot study in a Chinese population.
Fang Y; Yuan C; Xu Y; Chen J; Wu Z; Cao L; Yi Z; Hong W; Wang Y; Jiang K; Gao K; Cui X; Nierenberg AA;
J Clin Psychopharmacol; 2010 Aug; 30(4):357-64. PubMed ID: 20571433
[TBL] [Abstract][Full Text] [Related]
3. Dual-dual action? Combining venlafaxine and mirtazapine in the treatment of depression.
Malhi GS; Ng F; Berk M
Aust N Z J Psychiatry; 2008 Apr; 42(4):346-9. PubMed ID: 18330778
[TBL] [Abstract][Full Text] [Related]
4. Venlafaxine-mirtazapine combination in the treatment of persistent depressive illness.
Hannan N; Hamzah Z; Akinpeloye HO; Meagher D
J Psychopharmacol; 2007 Mar; 21(2):161-4. PubMed ID: 17329295
[TBL] [Abstract][Full Text] [Related]
5. Mirtazapine and venlafaxine in the management of collateral psychopathology during alcohol detoxification.
Liappas J; Paparrigopoulos T; Tzavellas E; Rabavilas A
Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jan; 29(1):55-60. PubMed ID: 15610945
[TBL] [Abstract][Full Text] [Related]
6. Second-generation antidepressant discontinuation and depressive relapse in adult patients with bipolar depression: results of a retrospective database analysis.
Fu AZ; Christensen DB; Hansen RA; Liu GG
Clin Ther; 2006 Jun; 28(6):979-89. PubMed ID: 16860180
[TBL] [Abstract][Full Text] [Related]
7. Mirtazapine and paroxetine in major depression: a comparison of monotherapy versus their combination from treatment initiation.
Blier P; Gobbi G; Turcotte JE; de Montigny C; Boucher N; Hébert C; Debonnel G
Eur Neuropsychopharmacol; 2009 Jul; 19(7):457-65. PubMed ID: 19345072
[TBL] [Abstract][Full Text] [Related]
8. Venlafaxine extended release versus conventional antidepressants in the remission of depressive disorders after previous antidepressant failure: ARGOS study.
Baldomero EB; Ubago JG; Cercós CL; Ruiloba JV; Calvo CG; López RP
Depress Anxiety; 2005; 22(2):68-76. PubMed ID: 16094658
[TBL] [Abstract][Full Text] [Related]
9. Induction of mania in depression by paroxetine.
Morishita S; Arita S
Hum Psychopharmacol; 2003 Oct; 18(7):565-8. PubMed ID: 14533140
[TBL] [Abstract][Full Text] [Related]
10. Venlafaxine plus mirtazapine as first-line treatment for melancholia: preliminary results.
Ruiz-Doblado S; Rueda-Villar T; Zurita-Gotor P; Sanz-Cortes S
J Psychopharmacol; 2010 Dec; 24(12):1837. PubMed ID: 21138931
[No Abstract] [Full Text] [Related]
11. Comparison of the antidepressant effects of venlafaxine and dosulepin in a naturalistic setting.
Bukh JD; Jørgensen MB; Dam H; Plenge P
Nord J Psychiatry; 2009; 63(4):347-51. PubMed ID: 19347769
[TBL] [Abstract][Full Text] [Related]
12. Clinical application of paroxetine for tapering benzodiazepine use in non-major-depressive outpatients visiting an internal medicine clinic.
Nakao M; Takeuchi T; Nomura K; Teramoto T; Yano E
Psychiatry Clin Neurosci; 2006 Oct; 60(5):605-10. PubMed ID: 16958945
[TBL] [Abstract][Full Text] [Related]
13. New antidepressants and the cytochrome P450 system: focus on venlafaxine, nefazodone, and mirtazapine.
Owen JR; Nemeroff CB
Depress Anxiety; 1998; 7 Suppl 1():24-32. PubMed ID: 9597349
[TBL] [Abstract][Full Text] [Related]
14. Mirtazapine versus venlafaxine for the treatment of somatic symptoms associated with major depressive disorder: a randomized, open-labeled trial.
Kang EH; Lee IS; Chung SK; Lee SY; Kim EJ; Hong JP; Oh KS; Woo JM; Kim S; Park JE; Yu BH
Psychiatry Res; 2009 Sep; 169(2):118-23. PubMed ID: 19695711
[TBL] [Abstract][Full Text] [Related]
15. [Unipolar depression suddenly switches to hypomania in a patient who has just started taking venlafaxine].
Krol DG; Nolen WA
Tijdschr Psychiatr; 2006; 48(5):405-8. PubMed ID: 16956033
[TBL] [Abstract][Full Text] [Related]
16. [Pattern of usage of new antidepressants in clinical practice].
Montejo AL; Gilaberte I; Fombellida C; Hylan TR; Sacristán JA
Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1998; 26(2):75-81. PubMed ID: 9595820
[TBL] [Abstract][Full Text] [Related]
17. Different effects of mirtazapine and venlafaxine on brain activation: an open randomized controlled fMRI study.
Frodl T; Scheuerecker J; Schoepf V; Linn J; Koutsouleris N; Bokde AL; Hampel H; Möller HJ; Brückmann H; Wiesmann M; Meisenzahl E
J Clin Psychiatry; 2011 Apr; 72(4):448-57. PubMed ID: 20868630
[TBL] [Abstract][Full Text] [Related]
18. A controlled study of the efficacy and safety of mianserin and amitriptyline in depressive inpatients.
Möller HJ; Kasper S; Müller H; Kissling W; Fuger J; Ruhrmann S
Pharmacopsychiatry; 1995 Nov; 28(6):249-52. PubMed ID: 8773291
[TBL] [Abstract][Full Text] [Related]
19. Treatment with mirtazapine and venlafaxine increases noradrenaline excretion in depressed patients.
Lecei O; Lederbogen F; Gronau W; Scharnholz B; Terhardt J; Schilling C; Gilles M; Kopf D; Roth HJ; Weber-Hamann B; Deuschle M
J Clin Psychopharmacol; 2012 Aug; 32(4):574-6. PubMed ID: 22760352
[No Abstract] [Full Text] [Related]
20. Venlafaxine, but not mirtazapine lowers retinol-binding protein 4 serum concentrations in nondiabetic depressed patients.
Deuschle M; Angermeier T; Westphal S; Lederbogen F; Gilles M; Frankhauser P; Schilling C; Onken V; Weber-Hamann B; Kopf D
Psychother Psychosom; 2010; 79(2):123-5. PubMed ID: 20090399
[No Abstract] [Full Text] [Related]
[Next] [New Search]
